# Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy

> **NCT01168908** · PHASE2 · TERMINATED · sponsor: **Hugo W. Moser Research Institute at Kennedy Krieger, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy
- Becker Muscular Dystrophy

## Interventions

- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT01168908
- **Lead sponsor:** Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** As recommended by the DSMB.
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01168908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01168908, "Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01168908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*